ArticleNeurosurgical review2026
Cerebral bypass for symptomatic vertebrobasilar dolichoectasia.
Article in Neurosurgical review, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The standard therapeutic strategies for vertebrobasilar dolichoectasia (VBD) are controversial due to their complexity, high risks and great complications. The current study is conducted to describe the use of cerebral bypass to treat symptomatic VBD. This retrospective study from 2019 to 2024 involved 20 patients who underwent cerebral bypass to treat symptomatic VBD. Cerebral ischemia and compression were the main presentations of patients with VBD. Dissecting, partially thrombosed and incorporate important perforating arteries were the morphological characteristics of VBD. Among the entire cohort, fourteen patients accepted the high-flow bypass and six patients underwent low-flow bypass. Clinical improvement occurred in 16 of the 20 patients, but decrease in 4 patients due to cerebral infarction or hematoma postoperatively. One patient died after the operation because of cerebral infarction. The mean follow-up period was 37 months, and during the follow-up period, all bypasses were patent, and no new deaths could be found. Treatment of complex VBD is challenging, base on a more precise preoperative assessment, cerebral bypass may be an effective treatment for complex VBD that does not respond to conservative management or other intervention options.
Indexed as
Identifiers
41575654What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.